Among those tumors, medulloblastoma is grouped into four distinct molecular subgroups in terms of gene expression patterns, one of which is SHH group (43), in which the amplifications of MYCN and MYCL are most frequently observed, defining its pathological significance in medulloblastoma (44). The gene discussed is SHH; the disease is medulloblastoma.